Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 6;20(13):3988-3991.
doi: 10.1021/acs.orglett.8b01561. Epub 2018 Jun 15.

Hexafluoroisopropanol as the Acid Component in the Passerini Reaction: One-Pot Access to β-Amino Alcohols

Jordy M Saya  1 , Rayan Berabez  1 , Pim Broersen  1 , Imme Schuringa  1 , Art Kruithof  1 , Romano V A Orru  1 , Eelco Ruijter  1
Affiliations

Hexafluoroisopropanol as the Acid Component in the Passerini Reaction: One-Pot Access to β-Amino Alcohols

Jordy M Saya et al. Org Lett. .

Abstract

A new Passerini-type reaction in which hexafluoroisopropanol functions as the acid component is reported. The reaction tolerates a broad range of isocyanides and aldehydes, and the formed imidates can be reduced toward β-amino alcohols under mild and metal-free conditions. In addition, the imidate products were shown to undergo an unprecedented retro-Passerini-type reaction under microwave conditions, providing valuable mechanistic information about the Passerini reaction and its variations.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Scheme 1
Scheme 1. Novel Passerini-Type Reactions
Scheme 2
Scheme 2. Scope of the Passerini-Type Reaction,
Standard conditions: isocyanide (1 mmol), aldehyde (1.3 mmol), HFIP (3 mmol) in CH2Cl2 (1 M), rt. Isolated yields. HFIP (0.1 M) was used as the solvent.
Scheme 3
Scheme 3. Scope of the One-Pot β-Amino Alcohol Synthesis,
Standard conditions: isocyanide (1 mmol), aldehyde (1.3 mmol), HFIP (3 mmol) in CH2Cl2 (1 M), rt, next diluted with HFIP (0.1 M), then BH3·NH3 (3 mmol) and TFA (5 mmol). Isolated yields. No TFA.
Scheme 4
Scheme 4. Synthesis of Propranolol and (±)-Rivaroxaban
Scheme 5
Scheme 5. Concerted Mechanism of the Passerini Reaction
See this image and copyright information in PMC

References

    1. Bienaymé H.; Hulme C.; Oddon G.; Schmitt P. Chem. - Eur. J. 2000, 6, 3321. 10.1002/1521-3765(20000915)6:18<3321::AID-CHEM3321>3.0.CO;2-A. - DOI - PubMed
    2. Sunderhaus J. D.; Martin S. F. Chem. - Eur. J. 2009, 15, 1300. 10.1002/chem.200802140. - DOI - PMC - PubMed
    3. Dömling A.; Wang W.; Wang K. Chem. Rev. 2012, 112, 3083. 10.1021/cr100233r. - DOI - PMC - PubMed
    4. van der Heijden G.; Ruijter E.; Orru R. Synlett 2013, 24, 666. 10.1055/s-0032-1318222. - DOI
    5. Cioc R. C.; Ruijter E.; Orru R. V. A. Green Chem. 2014, 16, 2958. 10.1039/C4GC00013G. - DOI
    6. Rotstein B. H.; Zaretsky S.; Rai V.; Yudin A. K. Chem. Rev. 2014, 114, 8323. 10.1021/cr400615v. - DOI - PubMed
    7. Zarganes-Tzitzikas T.; Chandgude A. L.; Dömling A. Chem. Rec. 2015, 15, 981. 10.1002/tcr.201500201. - DOI - PubMed
    1. Dömling A.; Ugi I. Angew. Chem., Int. Ed. 2000, 39, 3168. 10.1002/1521-3773(20000915)39:18<3168::AID-ANIE3168>3.0.CO;2-U. - DOI - PubMed
    2. Akritopoulou-Zanze I. Curr. Opin. Chem. Biol. 2008, 12, 324. 10.1016/j.cbpa.2008.02.004. - DOI - PubMed
    3. van Berkel S. S.; Bögels B. G. M.; Wijdeven M. A.; Westermann B.; Rutjes F. P. J. T. Eur. J. Org. Chem. 2012, 2012, 3543. 10.1002/ejoc.201200030. - DOI
    4. Sadjadi S.; Heravi M. M.; Nazari N. RSC Adv. 2016, 6, 53203. 10.1039/C6RA02143C. - DOI
    5. Giustiniano M.; Basso A.; Mercalli V.; Massarotti A.; Novellino E.; Tron G. C.; Zhu J. Chem. Soc. Rev. 2017, 46, 1295. 10.1039/C6CS00444J. - DOI - PubMed
    1. Passerini M.; Simone L. Gazz. Chim. Ital. 1921, 51, 126.
    1. Ugi I.; Steinbrückner C. Chem. Ber. 1961, 94, 734. 10.1002/cber.19610940323. - DOI
    1. Tron G. C. Eur. J. Org. Chem. 2013, 2013, 1849. 10.1002/ejoc.201201660. - DOI
    2. El Kaïm L.; Grimaud L. Eur. J. Org. Chem. 2014, 2014, 7749. 10.1002/ejoc.201402783. - DOI
    3. Koopmanschap G.; Ruijter E.; Orru R. V. A. Beilstein J. Org. Chem. 2014, 10, 544. 10.3762/bjoc.10.50. - DOI - PMC - PubMed
    4. Maleki A.; Sarvary A. RSC Adv. 2015, 5, 60938. 10.1039/C5RA11531K. - DOI
    5. Sharma U. K.; Sharma N.; Vachhani D. D.; Van Der Eycken E. V. Chem. Soc. Rev. 2015, 44, 1836. 10.1039/C4CS00253A. - DOI - PubMed
    6. Shaaban S.; Abdel-Wahab B. F.; Saad Shaaban B. Mol. Diversity 2016, 20, 233. 10.1007/s11030-015-9602-6. - DOI - PubMed
    7. Banfi L.; Basso A.; Lambruschini C.; Moni L.; Riva R. Chem. Heterocycl. Compd. 2017, 53, 382. 10.1007/s10593-017-2065-1. - DOI

Publication types

LinkOut - more resources